Bacterin Announces Earnings Release and Conference Call Date for 2013 Fourth Quarter and Full Year Results BELGRADE, MT

Bacterin Announces Earnings

Conference Call Date for 2013 Fourth Quarter and Full

BELGRADE, MT, February

25, 2014 -- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft

material and coatings for medical applications, today announced that it will release its financial results for the period ended December

31, 2013, on March 19, 2014 at the close of the financial markets.

An accompanying conference

call hosted by Dan Goldberger, Chief Executive Officer, and John Gandolfo, Chief Financial Officer, to discuss results will be

held at 10:00 a.m. ET, on March 20, 2014. Please refer to the information below for conference call dial-in information

and webcast registration.

Following the live call,

a replay will be available on the Company's website, www.bacterin.com, under "Investor Info".

About Bacterin International

Bacterin International

Holdings, Inc. (NYSE MKT: BONE) develops, manufactures and markets biologics products to domestic and international markets. These

products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone

growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other

Bacterin's Medical Device

division develops, employs, and licenses coatings for various medical device applications. For further information, please visit

Important Cautions Regarding Forward-looking

This news release contains certain disclosures

that may be deemed forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are

subject to significant risks and uncertainties. Forward-looking statements include statements that are predictive in nature, that

depend upon or refer to future events or conditions, or that include words such as "continue," "efforts," "expects,"

"anticipates," "intends," "plans," "believes," "estimates," "projects,"

"forecasts," "strategy," "will," "goal," "target," "prospects," "potential,"

"optimistic," "confident," "likely," "probable" or similar expressions or the negative

thereof. Statements of historical fact also may be deemed to be forward-looking statements. We caution that these statements by

their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors,

including, among others: the Company's ability to launch beta and full product releases; the Company's ability to meet its obligations

under existing and anticipated contractual obligations; the Company's ability to develop, market, sell and distribute desirable

applications, products and services and to protect its intellectual property; the ability of the Company's sales force to achieve

expected results; the ability of the Company's customers to pay and the timeliness of such payments; the Company's ability to obtain

financing as and when needed; changes in consumer demands and preferences; the Company's ability to attract and retain management

and employees with appropriate skills and expertise; the impact of changes in market, legal and regulatory conditions and in the

applicable business environment, including actions of competitors; and other factors. Additional risk factors are listed in the

Company's Annual Report on Form 10-K and Quarterly Reports on 10-Q under the heading "Risk Factors." The Company undertakes

no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the

date hereof or to reflect the occurrence of unanticipated events, except as required by law.